BACKGROUND: HLA class-I mismatches selectively induce antibody formation after kidney transplantation. The de novo development of donor-specific IgG HLA class-I antibodies may be dependent on the HLA class-II background of the patient by presenting T-helper epitopes within the recognized HLA class-I antigens. METHODS: The correlation between antibody production against mismatched donor human leukocyte antigens (HLA) class I and the number of HLA class II-restricted predicted indirectly recognizable HLA epitopes (PIRCHE-II) in the respective HLA class-I mismatches was investigated. To this end, we analyzed sera taken after nephrectomy from a cohort of 21 non-immunized individuals that received a renal transplant. RESULTS: Fourty-nine HLA class-I mismatches were found which all contained immunogenic eplets according to HLAMatchmaker. Donor specific HLA antibody responses were detected against 38 HLA class-I mismatches after nephrectomy. These mismatches were found to contain a larger number of PIRCHE-II when compared to mismatches which did not induce donor specific HLA antibodies. Most PIRCHE-II (68%) were not part of an eplet as defined by HLAMatchmaker. CONCLUSIONS: Our data suggest that presentation of donor-derived HLA class-I peptides by recipient HLA class-II molecules plays a significant role in de novo development of donor-specific IgG HLA antibodies.
BACKGROUND: HLA class-I mismatches selectively induce antibody formation after kidney transplantation. The de novo development of donor-specific IgG HLA class-I antibodies may be dependent on the HLA class-II background of the patient by presenting T-helper epitopes within the recognized HLA class-I antigens. METHODS: The correlation between antibody production against mismatched donorhuman leukocyte antigens (HLA) class I and the number of HLA class II-restricted predicted indirectly recognizable HLA epitopes (PIRCHE-II) in the respective HLA class-I mismatches was investigated. To this end, we analyzed sera taken after nephrectomy from a cohort of 21 non-immunized individuals that received a renal transplant. RESULTS: Fourty-nine HLA class-I mismatches were found which all contained immunogenic eplets according to HLAMatchmaker. Donor specific HLA antibody responses were detected against 38 HLA class-I mismatches after nephrectomy. These mismatches were found to contain a larger number of PIRCHE-II when compared to mismatches which did not induce donor specific HLA antibodies. Most PIRCHE-II (68%) were not part of an eplet as defined by HLAMatchmaker. CONCLUSIONS: Our data suggest that presentation of donor-derived HLA class-I peptides by recipient HLA class-II molecules plays a significant role in de novo development of donor-specific IgG HLA antibodies.
Authors: Jun Zou; Tao Wang; Meilun He; Yung-Tsi Bolon; Shahinaz M Gadalla; Steven G E Marsh; Michelle Kuxhausen; Robert Peter Gale; Akshay Sharma; Amer Assal; Tim Prestidge; Mahmoud Aljurf; Jan Cerny; Sophie Paczesny; Stephen R Spellman; Stephanie J Lee; Stefan O Ciurea Journal: Transplant Cell Ther Date: 2021-11-11
Authors: Kirsten A Thus; Roel A de Weger; Talitha A de Hoop; Valeria E Boers Trilles; Jürgen Kuball; Eric Spierings Journal: Chimerism Date: 2015-12-15
Authors: Jenny N Tran; Oliver P Günther; Karen R Sherwood; Franz Fenninger; Lenka L Allan; James Lan; Ruth Sapir-Pichhadze; Rene Duquesnoy; Frans Claas; Steven G E Marsh; W Robert McMaster; Paul A Keown Journal: Commun Biol Date: 2021-05-14